Lifeward R&D Spending Growth & History (LFWD)
Lifeward's r&d spending was $3.2M for fiscal 2025.
View full Lifeward company overviewLifeward annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.2M | −$1.4M | −29.75% |
| 2024 | 2024-12-31 | $4.6M | $477,000 | +11.50% |
| 2023 | 2023-12-31 | $4.1M | $117,000 | +2.90% |
| 2022 | 2022-12-31 | $4.0M | $1.1M | +37.16% |
| 2021 | 2021-12-31 | $2.9M | −$520,000 | −15.03% |
| 2020 | 2020-12-31 | $3.5M | −$1.9M | −35.32% |
| 2019 | 2019-12-31 | $5.3M | −$2.0M | −27.23% |
| 2018 | 2018-12-31 | $7.3M | $1.3M | +21.63% |
| 2017 | 2017-12-31 | $6.0M | −$3.0M | −33.07% |
| 2016 | 2016-12-31 | $9.0M | $3.1M | +52.06% |
| 2015 | 2015-12-31 | $5.9M | −$2.6M | −30.67% |
| 2014 | 2014-12-31 | $8.6M | $6.1M | +247.67% |
| 2013 | 2013-12-31 | $2.5M | $706,000 | +40.18% |
| 2012 | 2012-12-31 | $1.8M | — | — |
Lifeward quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.8M | $987,000 | +128.68% |
| Q1 2026 | 2026-03-31 | $5.8M | $4.9M | +536.71% |
| Q4 2025 | 2025-12-31 | $843,000 | −$288,000 | −25.46% |
| Q3 2025 | 2025-09-30 | $721,000 | −$277,000 | −27.76% |
| Q2 2025 | 2025-06-30 | $767,000 | −$438,000 | −36.35% |
| Q1 2025 | 2025-03-31 | $918,000 | −$373,000 | −28.89% |
| Q4 2024 | 2024-12-31 | $1.1M | −$187,000 | −14.19% |
| Q3 2024 | 2024-09-30 | $998,000 | −$264,000 | −20.92% |
| Q2 2024 | 2024-06-30 | $1.2M | $389,000 | +47.67% |
| Q1 2024 | 2024-03-31 | $1.3M | $539,000 | +71.68% |
| Q4 2023 | 2023-12-31 | $1.3M | $215,000 | +19.49% |
| Q3 2023 | 2023-09-30 | $1.3M | $197,000 | +18.50% |
| Q2 2023 | 2023-06-30 | $816,000 | −$140,000 | −14.64% |
| Q1 2023 | 2023-03-31 | $752,000 | −$155,000 | −17.09% |
| Q4 2022 | 2022-12-31 | $1.1M | $407,000 | +58.48% |
| Q3 2022 | 2022-09-30 | $1.1M | $427,000 | +66.93% |
| Q2 2022 | 2022-06-30 | $956,000 | $146,000 | +18.02% |
| Q1 2022 | 2022-03-31 | $907,000 | $112,000 | +14.09% |
| Q4 2021 | 2021-12-31 | $696,000 | −$68,000 | −8.90% |
| Q3 2021 | 2021-09-30 | $638,000 | −$118,000 | −15.61% |
| Q2 2021 | 2021-06-30 | $810,000 | −$144,000 | −15.09% |
| Q1 2021 | 2021-03-31 | $795,000 | −$190,000 | −19.29% |
| Q4 2020 | 2020-12-31 | $764,000 | −$292,000 | −27.65% |
| Q3 2020 | 2020-09-30 | $756,000 | −$262,000 | −25.74% |
| Q2 2020 | 2020-06-30 | $954,000 | −$906,000 | −48.71% |
| Q1 2020 | 2020-03-31 | $985,000 | −$429,000 | −30.34% |
| Q4 2019 | 2019-12-31 | $1.1M | −$648,000 | −38.03% |
| Q3 2019 | 2019-09-30 | $1.0M | −$579,000 | −36.26% |
| Q2 2019 | 2019-06-30 | $1.9M | −$37,000 | −1.95% |
| Q1 2019 | 2019-03-31 | $1.4M | −$737,000 | −34.26% |
| Q4 2018 | 2018-12-31 | $1.7M | $95,000 | +5.90% |
| Q3 2018 | 2018-09-30 | $1.6M | −$21,000 | −1.30% |
| Q2 2018 | 2018-06-30 | $1.9M | $512,000 | +36.97% |
| Q1 2018 | 2018-03-31 | $2.2M | $721,000 | +50.42% |
| Q4 2017 | 2017-12-31 | $1.6M | −$682,000 | −29.77% |
| Q3 2017 | 2017-09-30 | $1.6M | −$350,000 | −17.78% |
| Q2 2017 | 2017-06-30 | $1.4M | −$1.7M | −54.94% |
| Q1 2017 | 2017-03-31 | $1.4M | −$265,000 | −15.63% |
| Q4 2016 | 2016-12-31 | $2.3M | $604,000 | +35.80% |
| Q3 2016 | 2016-09-30 | $2.0M | $705,000 | +55.82% |
| Q2 2016 | 2016-06-30 | $3.1M | $1.6M | +112.00% |
| Q1 2016 | 2016-03-31 | $1.7M | $158,000 | +10.28% |
| Q4 2015 | 2015-12-31 | $1.7M | — | — |
| Q3 2015 | 2015-09-30 | $1.3M | — | — |
| Q2 2015 | 2015-06-30 | $1.4M | — | — |
| Q1 2015 | 2015-03-31 | $1.5M | — | — |
Lifeward r&d spending trends
Over the last five fiscal years, Lifeward's r&d spending decreased from $3.5M to $3.2M, a change of −$210,000. The latest reported quarter, Q2 2026, shows $1.8M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lifeward source filings ↗